Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 19,952 |
|
|||||
| News | - | ||||||
| Day High | 10.96 | Low High |
|||||
| Day Low | 10.36 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| GH Research PLC | GHRS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.01 | 0.10% | 10.51 | 15:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 10.47 | 10.36 | 10.96 | 10.51 | 10.50 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 413 | 19,952 | US$ 10.57 | US$ 210,857 | - | 5.05 - 14.70 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:20:23 | 2 | US$ 10.71 | USD |
GH Research PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 548.38M | 52.03M | - | 0 | -35.59M | -0.68 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
GH Research News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GHRS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.23 | 12.26 | 10.30 | 11.20 | 50,035 | -0.72 | -6.41% |
| 1 Month | 10.56 | 12.26 | 10.30 | 11.12 | 100,671 | -0.05 | -0.47% |
| 3 Months | 7.80 | 12.26 | 6.82 | 9.59 | 128,670 | 2.71 | 34.74% |
| 6 Months | 7.00 | 12.26 | 5.05 | 8.14 | 113,930 | 3.51 | 50.14% |
| 1 Year | 7.82 | 14.70 | 5.05 | 9.24 | 91,420 | 2.69 | 34.40% |
| 3 Years | 22.00 | 30.43 | 5.05 | 13.86 | 87,774 | -11.49 | -52.23% |
| 5 Years | 22.00 | 30.43 | 5.05 | 13.86 | 87,774 | -11.49 | -52.23% |
GH Research Description
| GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. |
